AVH — AVITA Medical Income Statement
0.000.00%
Last trade - 00:00- AU$347.96m
- AU$271.26m
- $50.14m
- 29
- 20
- 34
- 17
Annual income statement for AVITA Medical, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 June 30th | 2021 June 30th | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final |
| Revenue | ||||
| Total Revenue | 14.3 | 29.2 | 34.4 | 50.1 |
| Cost of Revenue | ||||
| Gross Profit | 11.6 | 23.5 | 28.8 | 42.6 |
| Selling / General / Administrative Expenses | ||||
| Research And Development | ||||
| Unusual Expense / Income | ||||
| Other Operating Expenses | ||||
| Total Operating Expenses | 56.9 | 55.8 | 61.9 | 92.8 |
| Operating Profit | -42.7 | -26.5 | -27.5 | -42.7 |
| Total Net Non Operating Interest Income / Expense | ||||
| Other Net Non Operating Costs | ||||
| Net Income Before Taxes | -42 | -26.5 | -26.6 | -35.3 |
| Provision for Income Taxes | ||||
| Net Income After Taxes | -42 | -26.6 | -26.7 | -35.4 |
| Net Income Before Extraordinary Items | ||||
| Net Income | -42 | -26.6 | -26.7 | -35.4 |
| Income Available to Common Shareholders Excluding Extraordinary Items | ||||
| Income Available to Common Shareholders Including Extraordinary Items | ||||
| Diluted Net Income | -42 | -26.6 | -26.7 | -35.4 |
| Diluted Weighted Average Shares | ||||
| Basic EPS Including Extraordinary Items | ||||
| Diluted EPS Including Extraordinary Items | ||||
| Diluted EPS Excluding Extraordinary Items | ||||
| Normalised Income Before Taxes | ||||
| Normalised Income After Taxes | ||||
| Normalised Income Available to Common Shareholders | ||||
| Diluted Normalised EPS | -2.06 | -1.17 | -1.06 | -1.39 |